Aurinia Pharmaceuticals Inc. (AUPH) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16
	10-K	10-K	10-K	10-K	6-K	6-K	6-K
ASSETS
Current assets
Cash, cash equivalents and restricted cash
Short-term investments
Accounts receivable, net	13.5	15.4		0.4
Inventories, net	24.8	19.3	13.9
Prepaid expenses	13.6	11.7	7.2	8.8
Other current assets	1.3	0.8
Total current assets	442.5	513.3	419.4	315.1

Non-current assets
Other non-current assets	13.3	11.8	0.2	0.2
Property and equipment, net	3.7	4.4	4.8	0.1
Acquired intellectual property and other intangible assets, net	6.4	8.4	9.3	8.9
Total assets	470.9	543.4	463.7	324.3

LIABILITIES
Current liabilities
Accounts payable and accrued liabilities	40.0	34.9	24.8	11.2
Deferred revenue	3.1	0.2
Other current liabilities	2.0	4.5	6.4	0.1
Operating lease liabilities	0.9	1.1	0.8
Total current liabilities	46.1	40.6	32.0	11.3

Non-current liabilities
Operating lease liabilities	7.2	7.7	7.6
Deferred compensation and other non-current liabilities	12.2	16.0	16.3	6.2
Total liabilities	65.4	64.3	55.9	25.7

Commitments and contingencies (Note 17)
SHAREHOLDER’S EQUITY
Common shares	1,185.3	1,177.1	944.3	746.5
Additional paid-in capital	85.5	59.0	39.4	25.4
Accumulated other comprehensive loss	-1.1	-0.9	-0.8	-0.8
Accumulated deficit	-864.3	-756.1	-575.2	-472.5
Total shareholders' equity	405.4	479.1	407.8	298.6
Total liabilities and shareholders' equity	470.9	543.4	463.7	324.3